UK's medtech firm Oxford Cancer Analytics bags 10.6MOXcan has raised $11M for developing next-gen blood tests aimed at early lung cancer detection.Dr. Heinrich Roder has been appointed SVP of Research & Development, bringing extensive expertise in cancer diagnostics.
Discovery of Proteins and Metabolites Implicated in Mental Illness and Neurodevelopmental DisordersUnderstanding mental illness requires examining protein expression and modifications, not just gene expression.Key gaps exist in research on proteomics related to mental illness and neurodevelopment.
Researchers identify biomarkers in blood to predict liver cancer risk - Harvard GazetteIdentifying blood proteins may enhance liver cancer risk prediction and treatment options.